Results 181 to 190 of about 2,479 (207)

Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab

The Journal of Allergy and Clinical Immunology: In Practice, 2023
Beatriz, González-Cano, Victoria, Villalobos-Violán, Mar, Gandolfo-Cano, Maria Jesús, Trujillo-Trujillo, Ester, Mohedano-Vicente, Eloína, González-Mancebo   +5 more
openaire   +2 more sources

Migräneprophylaxe: Fremanezumab effektiv und verträglich

DNP - Der Neurologe & Psychiater, 2022
openaire   +1 more source

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Lancet, The, 2019
Michel D Ferrari, Andrew H Ahn, Hans-Christoph Diener   +2 more
exaly  

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

JAMA - Journal of the American Medical Association, 2018
Stephen D Silberstein, Peter Goadsby
exaly  

Fremanezumab as Add‐On Treatment for Patients Treated With Other Migraine Preventive Medicines

Headache, 2017
David W Dodick
exaly  

Migräne: Fremanezumab ist wirksam

NeuroTransmitter, 2018
openaire   +1 more source

Summary of opinion: Ajovy,fremanezumab

Case Medical Research, 2019
openaire   +2 more sources

Erenumab/fremanezumab/galcanezumab

Reactions Weekly, 2019
openaire   +1 more source

Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials

Cephalalgia, 2019
David W Dodick
exaly  

Fremanezumab auf dem Weg

NeuroTransmitter, 2018
openaire   +1 more source